C
linical practice guidelines are ''systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances.'' 1 Clinical practice guidelines have been shown to influence practice in settings where the guidelines have clear recommendations for or against a particular intervention or process. [2] [3] [4] [5] [6] In these settings, clinical guidelines may reduce variation in health care quality and improve equity in health care.
However, the effect of guidelines that advocate shared decision making on physician practice patterns is unknown. Shared decision making is the process by which physicians and patients share information with each other, take steps to participate in the decision-making process, and agree on a course of action. 7 Prostate cancer-screening guidelines advocate shared decision making. Prostate cancer is the most common cancer in US men, but the utility of screening for prostate cancer with a prostate-specific antigen (PSA) test is controversial. 8 Although there are 2 large randomized clinical trials currently in progress to determine the utility of PSA screening to date, 9, 10 it is unknown whether screening reduces mortality from prostate cancer. Therefore, beginning in 1996 and 1997, the guidelines from the American Cancer Society, 11 American College of Physicians, 12 and the US Preventive Services Task Force 13 recommended shared decision about PSA screening (see the appendix).
A previous physician focus group study demonstrated that physicians who routinely screen with a PSA were more likely to report that clinical practice guidelines were not a factor in their screening decisions. 14 We hypothesized that physicians who report a strong effect of guidelines on clinical practice are more likely to be variable PSA screeners because PSA screening guidelines call for incorporating patient preferences and values in decision making. As considerable time, effort, and resources are devoted to developing and implementing guidelines, knowing the effect of guidelines that promote shared decision making on physician practice patterns has important implications on future efforts to create and implement guidelines.
METHODS
This study was approved by the Institutional Review Board at the University of Pennsylvania. We used cross-sectional survey data from the 1998-1999 (Round Two) Community Tracking Study (CTS) Physician Survey. 15, 16 The CTS Physician Survey is a biannual longitudinal telephone survey of non-federally employed physicians at 60 sites (51 metropolitan US areas and 9 nonmetropolitan US areas) and of a supplemental national sample of physicians conducted by the Center for Studying Health System Change, which is sponsored by the Robert Wood Johnson Foundation. Data for Round Two were collected just after the concept of shared decision making was introduced in the guidelines in 1996 and 1997 in response to the widespread interest in and rapid uptake of PSA screening for prostate cancer. 17 The aim of the CTS Physician Survey is to track changes in the health care system and the effects of these changes on the delivery of care by physicians. Participants of the CTS Physician Survey are physicians who provide direct care to patients at least 20 h per week in an office-based or hospital practice. It excludes residents and fellows. Details of the survey are available at www.hschange.org/index.cgi? data = 98. The total number of completed interviews for the 1998-1999 survey was 12,280, for a response rate of 60.9%.
The CTS Physician Survey contains information on physician demographics, medical education, specialty, board certification, practice setting, number of years in practice, practice ownership, practice revenue, source of practice revenue, and provision of charity care. In addition, the survey asks about the perceived effect of clinical practice guidelines on practice. The 1998-1999 round of the CTS Physician Survey also measured PSA screening practice style using a case vignette.
Selection of Study Subjects
Of the 12,280 total responders in the 1998-1999 CTS Physician Survey, 7556 were primary care physicians. For this study, we excluded primary care physicians practicing pediatrics, obstetrics and gynecology, and subspecialties (n = 3642) because they are less likely to provide care for the reference patient described in the case vignette: an adult male patient presenting for prostate cancer screening. The final analytic sample consists of 3914 primary care physicians in family practice, internal medicine, and general practice.
Data Collection
Data for the 60 sites were collected by the Center for Studying Health System Change using stratified random sampling with probability proportional to population size. The supplemental sample was selected with stratified random sampling and was included to increase the precision of the national estimates. The sample frame was developed by combining lists of physicians from the American Medical Association and the American Osteopathic Association. Primary care physicians were oversampled in the site sample. The CTS Physician Survey was conducted using a telephone interview. Use of the data was made available through a restricted data use agreement between the principal investigator and the Inter-university Consortium for Political and Social Research at the University of Michigan.
Dependent Variable
The dependent variable is the physician responses to the PSA screening case vignette, which reads as follows: Responses ranged from 0% to 100%. Responses were collapsed to create 3 categories: consistent screeners, consistent nonscreeners, and variable screeners, to represent those who would screen all (100%), none (0%), and some (1%-99%) of the patients represented in the case vignette, respectively. Each of these 3 variables were dichotomized to compare the level to all other physicians, thereby creating three 0/1 variables.
Independent Variables
The independent variable in this study is the physicians' perceived effect of guidelines on their practice derived from the following question:
How large an effect does your use of formal, written practice guidelines such as those generated by physician organizations, insurance companies or HMOs [health maintenance organizations] or government agencies, have on your practice of medicine?
Each response was based on a 6-point scale with anchors at no effect and very large effect. For this analysis, we dichotomized the independent variable into no effect (reference) versus any magnitude effect.
Covariates
The multivariate models adjust for physician age; gender; race; Latino ethnicity; practice specialty; board certification status; foreign medical graduate status; practice setting; number of years in practice; salaried status; income in 1997; Medicare, Medicaid, and managed care as a source of practice revenue; and provision of any charity care.
Statistical Analysis
All statistical analyses were conducted using Stata/SE version 8.2. 18 Descriptive statistics were used to examine the demographic and practice characteristics of consistent screeners, consistent nonscreeners, and variable screeners and their responses to the case vignette. An unadjusted and a multivariate logistic regression model were estimated for each of the 3 groups of physicians, consistent screeners, consistent nonscreeners, and variable screeners, that compared the perceived effect of guidelines in each of the screening group to the other 2 screening groups, yielding a total of 6 regression models. Multivariate models adjusted for physician and practice characteristics. All logistic regression models were estimated taking into account the CTS Physician Survey's complex design. Given the fixed sample size for the current study of 3914 primary care physicians who participated in the 1998-1999 CTS Physician Survey and completed the PSA screening vignette, using a 2-sided statistical test, with an a set at .05 and a minimum detectable difference of 10% probability of being a consistent screener among those who declare no effect versus those who declare any effect of guidelines, this study had 93% power. Figure 1 shows the frequency of physician responses to the case vignette. The majority (60%) of physicians reported they would recommend screening to all asymptomatic 60-year-old white men (consistent screeners), whereas only 13% reported they would not recommend screening to any such patients (consistent nonscreeners). The remaining 27% of physicians reported that they would recommend screening to 1% to 99% of such patients (variable screeners).
RESULTS
Only 319 (8%) of the physicians perceived guidelines to have no effect on practice, whereas the remaining 3591 (92%) physicians perceived at least some effect of the guidelines. Of these, 13% reported a very small, 27% a small, 35% a moderate, 14% a large, and 4% a very large effect of guidelines on practice. Table 1 presents the physician and practice characteristics of physicians who were classified as consistent nonscreeners, variable screeners, and consistent screeners. P values are presented for the relationship between the 3 categories of screeners and the independent variable and are based on the np trend statistic. Compared with the remainder of physicians, physicians who were variable PSA screeners were least likely to be white (P = 0:003), most likely to practice internal medicine (P = 0:05), and most likely to be solo practioners (P < 0:0001). Table 2 shows the results of unadjusted and multivariate logistic regression models for the association between the perception of any effect of guidelines on practice and PSA screening pattern. After adjustment for demographic and practice characteristics, physicians who were variable PSA screeners were more likely to report any magnitude effect of guidelines on their practice when compared with physicians in the other 2 groups (adjusted odds ratio [AOR] = 1.73; 95% confidence interval [CI] = 1:25−2:38; P = 0:001). Given the heterogeneity in the comparison groups, we compared variable screeners to each of the other 2 groups in separate analyses. When variable screeners were compared with consistent screeners only (omitting the consistent nonscreeners), the AOR was 1.83 (95% CI = 1:32−2:54; P = 0:001; not shown in the table). A comparison with consistent nonscreeners did not yield statistically significant results (not shown in the table). Table 2 also shows that in multivariate models physicans who consistently screened their patients with a PSA test were significantly less likely to report any magnitude effect of guidelines on their clinical practice when compared with physicians in the other 2 groups (AOR = 0:61; 95% CI = 0:47−0:79; P < 0:0001). Physicians who consistently did not screen their patients did not signficantly differ in the reported effect of guidelines when compared with the other 2 groups of physicians (AOR = 1:16; 95% CI = 0:79−1:71; P = 0:43). Table 3 shows the results of the unadjusted and multivariate logistic regression models for the association between being a variable PSA screener (compared with all other physicians) and physician and practice characteristics as well as the perception that guidelines have any effect on practice (v. no effect). In both unadjusted and multivariate models, an income of $200,000 to $299,999, providing any charity care in the previous month, Medicaid as a source of practice revenue, and the perception that guidelines had an effect on practice were directly associated with being a variable screener. In addition, in multivariate models, nonwhite physicians were more likely to be a variable screeners, and Latino physicians were less likely to be variable screeners.
DECISION MAKING IN CLINICAL PRACTICE

DISCUSSION
One of the 1st clinical practice guidelines to be widely used was created in 1938 by the American Academy of Pediatrics to provide parameters for the immunization of children. 19 Clinical practice guidelines have since become commonplace, and as of 2007, there were 2249 clinical practice guidelines in the National Guideline Clearinghouse, the national repository of evidence-based guidelines. 20 Considerable time, effort, and resources are devoted to developing and implementing guidelines. 21 Thus, knowledge of how physicians perceive and interpret guidelines is important for providing high-quality care. To our knowledge, this one is the 1st study to use nationally representative physician survey data to examine physician PSA screening patterns and their perceived effect of guidelines on clinical practice.
Our research shows several important findings. First, the majority of physicians (60%) reported that they consistently recommend PSA screening to all their asymptomatic 60-year-old patients. This finding is consistent with previous research that has shown that many, if not most, physicians order screening PSAs at least occasionally. [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] Thus, it is not surprising that 75% of men older than 50 years in the United States have previously had a PSA test. 35 Second, although guidelines recommend shared decision making, only 27% of physicians are variable PSA screeners. Thus, the majority of physicians have a consistent screening strategy, indicating that they may be less responsive to patient values and preferences. From this perspective, the message of shared decision making appears to have had only a limited impact on clinical practice. Research on patients supports this inference. In a cross-sectional analysis of data from the 2000 National Health Interview Survey, approximately one third of men reported their physician did not discuss advantages and disadvantages of prostate cancer screening before offering testing. 36 Two additional studies suggest the problem is even more concerning: one fourth of men who have undergone PSA testing were unaware they had been tested. 37, 38 These findings add to the concern that a significant proportion of men are not being given the opportunity to make an informed decision about prostate cancer screening and that the prostate cancer screening guideline recommendation of shared decion making is not being implemented. Much research has been conducted on guideline implemenation. A recent literature review of the facilitators of guideline implementation found that among the 70 successful facilitators identified in the literature, 7 categories emerged: 1) data feedback, 2) reminders or checklists, 3) peer review and in-person feedback, 4) direct supervision, 5) in-service or other educational interventions, 6) mandates, and 7) monetary incentives. 39 Multifaceted interventions targeting different barriers to change are likely to be required to effectively change physician PSA screening behavior. [40] [41] [42] [43] Third, although only a small minority (8%) of physicians report that guidelines have no effect on their clinical practice, those physicians are much less likely to be variable PSA screeners. Our findings Note: HMO = health maintenance organization. In some cases, percentages do not add up to 100% because of rounding. a. P values are based on np trend.
are similar to prior focus group research 14 that shows that routine PSA screeners were less likely to be familiar with the guidelines about PSA screening compared with routine nonscreeners. In fact, in that same study, routine screeners were frequently unable to describe the recommendations of any specific organization, were unaware of the controversy about PSA screening, and believed that populationbased screening was universally endorsed. In addition, most routine screeners in that study said that clinical guidelines were not a factor in their screening decisions and that, instead, their practices were based on their clinical experience. Less is known about variable screeners, but one hypothesis is that physicians who are variable screeners interpret the current guidelines in a way that recognizes that screening decisions should be individualized. Based on the findings of this study, clinical guidelines that recommend individualized, informed, shared decision making appear to have some impact on clinical practice: Physicians who report guidelines have an effect on clinical practice are more likely to have PSA screening practice patterns consistent with shared decision making.
Fourth, the current research demonstrates that physicians who are consistent PSA screeners differ from those who are consistent nonscreeners and variable screeners in other ways. Compared with all the remainder of physicians, consistent PSA screeners are more likely to be older, male, white, and in practice longer and to have a higher income and are less likely to be board certified, salaried, and have the lowest proportion of Medicaid as a source of revenue. Conversely, consistent PSA nonscreeners had personal and practice characteristics that were the opposite of consistent screeners. It is possible that the demographic profile of the physicians who are routine screeners represents a group of physicians who are paternalistic, whereby patient input is not sought and thus practice variation is reduced.
Cooper and others 14 previously demonstrated that consistent screeners and consistent nonscreeners vary in substantive ways. The major factor influencing PSA practice patterns for consistent screeners was professional and personal experience that supported PSA screening and patient expectations to be screened, whereas the major factor influencing consistent nonscreeners was the lack of definitive evidence of the benefit of PSA screening.
Our study has several limitations. First, the question about screening guidelines in the CTS Physician Survey was not specific to PSA screening, and the data did not allow us to evaluate which clinical practice guidelines are responsible for the perceived effect of guidelines on practice, thereby creating the potential for misclassification bias. Physicians receive guidelines from multiple organizations through different media, and they assimilate the contents of these to largely varying degrees depending on the source. In fact, physicians may experience ''guideline fatigue'' and not adopt a clinical practice guideline at all. 44 A potential solution is to convene a multisociety task force composed of members of all the relevant organizations to design a single, uniform set of clinical practice guidelines about a topic, as was done with the case of colorectal cancer screening. 45 Although design and approval of these guidelines are more time and labor intensive, such guidelines have the potential to be much more widely and consistently implemented.
Second, the literature shows that there may be other important drivers of PSA screening that we did not have data for and thus could not adjust for, [47] [48] [49] [50] Fourth, there is the potential for nonresponse bias, given that the response rate for the 1998-1999 CTS Physician Survey was 61%, a response rate that is not unusually low for physician surveys. Finally, the inferences drawn from this crosssectional study are limited because this study cannot prove causality between the effect of guidelines and the PSA screening behavior of physicians.
Despite these limitations, this is one of the largest studies to examine the relationship between physician attitudes, guidelines, and PSA screening patterns. These results can inform health care policy makers who seek to improve the quality of cancer screening decisions and develop effective clinical guidelines. Note: PSA = prostate-specific antigen; OR = odds ratio; CI = confidence interval; HMO = health maintenance organization. A consistent screener is defined as screening with PSA at least 80% of patients represented by vignette. All P values are 2 tailed.
